Skip to content

Insider · CIK 0001462808

Stephen Michael Kelsey

officer

Files at RVMD (Revolution Medicines, Inc.). First filing Oct 16, 2024, latest Sep 18, 2026.

Stephen Michael Kelsey files SEC Form 4 as officer at RVMD (Revolution Medicines, Inc.). Since Oct 16, 2024, Stephen Michael Kelsey has reported 0 open-market buys worth $0 and 13 open-market sells worth $31M, the latest filed on Sep 18, 2026.

A track record needs three past buys with six months of prices behind them; Stephen Michael Kelsey has 0, so none is measured yet.

The newest scored trade: sold $1.1M of RVMD on Sep 16, 2026, filed Sep 18, 2026, scored 35 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 6 sells worth $23M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 13
$0 bought, $31M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RVMD: Revolution Medicines, Inc.

RVMDOct 9, 2026 · close 189.76

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$1.1M
5,569 shares
-2%+361% from low-11% from high
25Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$19M
92,531 shares
-24%+379% from low-8% from high
30Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$652k
4,175 shares
-1%+351% from low-4% from high
27Weak
RVMDsell 810b5-1
Revolution Medicines, Inc.
$428k
4,302 shares
-1%+218% from low-20% from high
26Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$418k
5,447 shares
-2%+149% from low-3% from high
20Weak
RVMDsell 310b5-1
Revolution Medicines, Inc.
$1.2M
25,000 shares
-8%+57% from low-20% from high
23Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$246k
5,367 shares
-2%+44% from low-26% from high
30Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$5.6M
125,000 shares
-32%+49% from low-24% from high
21Weak
RVMDsell 610b5-1
Revolution Medicines, Inc.
$171k
4,289 shares
-1%+28% from low-34% from high
21Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$129k
3,294 shares
-1%+6% from low-35% from high
22Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$212k
4,663 shares
-2%-
20Weak
RVMDsell 410b5-1
Revolution Medicines, Inc.
$978k
16,666 shares
-6%-
18Weak
RVMDsell 510b5-1
Revolution Medicines, Inc.
$825k
16,666 shares
-6%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 15, 2026 RVMD
Revolution Medicines, Inc.
5,415
0.00% of outstanding
$1.1MSep 15, 2026$19M
Sep 11, 2026 RVMD
Revolution Medicines, Inc.
92,531
0.04% of outstanding
$19MSep 11, 2026$652k
Jun 15, 2026 RVMD
Revolution Medicines, Inc.
4,071
0.00% of outstanding
$626kJun 15, 2026$428k
Mar 13, 2026 RVMD
Revolution Medicines, Inc.
3,901
0.00% of outstanding
$389kMar 16, 2026$418k
Dec 12, 2025 RVMD
Revolution Medicines, Inc.
5,296
0.00% of outstanding
$412kDec 15, 2025$1.5M
Sep 15, 2025 RVMD
Revolution Medicines, Inc.
5,296
0.00% of outstanding
$247kSep 15, 2025$5.7M
Sep 11, 2025 RVMD
REVOLUTION MEDICINES INC
150,000
0.08% of outstanding
$6.1MSep 11, 2025$171k
Jun 13, 2025 RVMD
Revolution Medicines, Inc.
3,732
0.00% of outstanding
$152kJun 16, 2025$129k
Mar 14, 2025 RVMD
Revolution Medicines, Inc.
3,611
0.00% of outstanding
$140kMar 17, 2025$212k
Dec 16, 2024 RVMD
Revolution Medicines, Inc.
4,604
0.00% of outstanding
$207kDec 16, 2024$2.0M
Nov 13, 2024 RVMD
REVOLUTION MEDICINES INC
16,666
0.01% of outstanding
$989kNov 13, 2024$1.5M
Oct 15, 2024 RVMD
REVOLUTION MEDICINES INC
16,666
0.01% of outstanding
$841kOct 14, 2024$2.2M

Transactions

Every row this insider has filed, 44 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-85$195.01$17k291,79125 d ago
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,484$199.30$1.1M286,30725 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+52,500$42.45$2.2M344,37628 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+40,031$40.74$1.6M384,40728 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-800$198.55$159k383,60728 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-11,833$200.11$2.4M371,77428 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-13,368$200.78$2.7M358,40628 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-21,447$201.75$4.3M336,95928 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-18,869$203.06$3.8M318,09028 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-17,949$203.87$3.7M300,14128 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,995$204.84$1.0M295,14628 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-3,270$205.81$673k291,87628 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-52,500$42.45$2.2M028 d ago
Sep 11, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-40,031$40.74$1.6M88,06928 d ago
Jun 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,175$156.12$652k291,876Jun 18, 2026
Mar 17, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,302$99.48$428k295,398Mar 19, 2026
Mar 1, 2026RVMD
Revolution Medicines, Inc.
AGrant or award
Common Stock
+21,100$0.00$0299,700Mar 3, 2026
Mar 1, 2026RVMD
Revolution Medicines, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+47,600$0.00$047,600Mar 3, 2026
Dec 16, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,447$76.82$418k278,600Dec 18, 2025
Oct 13, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+25,000$4.73$118k309,047Oct 15, 2025
Oct 13, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-25,000$48.54$1.2M284,047Oct 15, 2025
Oct 13, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-25,000$0.00$05,055Oct 15, 2025
Sep 16, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,367$45.82$246k284,047Sep 18, 2025
Sep 11, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+100,000$4.73$473k389,414Sep 15, 2025
Sep 11, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-44,059$43.58$1.9M345,355Sep 15, 2025
Sep 11, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-55,941$44.48$2.5M289,414Sep 15, 2025
Sep 15, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+25,000$4.73$118k314,414Sep 15, 2025
Sep 15, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-23,682$45.92$1.1M290,732Sep 15, 2025
Sep 15, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,318$46.93$62k289,414Sep 15, 2025
Sep 11, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-100,000$0.00$055,055Sep 15, 2025
Sep 15, 2025RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-25,000$0.00$030,055Sep 15, 2025
Jun 16, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,289$39.83$171k289,414Jun 18, 2025
Mar 17, 2025RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-3,294$39.04$129k293,051Mar 19, 2025
Mar 1, 2025RVMD
Revolution Medicines, Inc.
AGrant or award
Common Stock
+36,600$0.00$0296,345Mar 4, 2025
Mar 1, 2025RVMD
Revolution Medicines, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+128,100$0.00$0128,100Mar 4, 2025
Dec 16, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-4,663$45.40$212k259,745Dec 18, 2024
Nov 13, 2024RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+16,666$4.09$68k281,074Nov 15, 2024
Nov 13, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-13,778$58.49$806k267,296Nov 15, 2024
Nov 13, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,888$59.45$172k264,408Nov 15, 2024
Nov 13, 2024RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-16,666$0.00$06,666Nov 15, 2024
Oct 14, 2024RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+16,666$4.09$68k281,074Oct 16, 2024
Oct 14, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-14,056$49.38$694k267,018Oct 16, 2024
Oct 14, 2024RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,610$50.08$131k264,408Oct 16, 2024
Oct 14, 2024RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-16,666$0.00$023,332Oct 16, 2024

Questions about Stephen Michael Kelsey

Answered from the filings on this page, as of the latest one.

Is Stephen Michael Kelsey buying or selling?

In the last 12 months Stephen Michael Kelsey reported 0 open-market buys worth $0 and 6 open-market sells worth $23M on SEC Form 4; the latest was sold $1.1M of RVMD on Sep 16, 2026. Grants, option exercises and tax withholding are not counted.

How did Stephen Michael Kelsey's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Michael Kelsey has 0.

Where does Stephen Michael Kelsey file Form 4?

Stephen Michael Kelsey has filed Form 4 at RVMD (Revolution Medicines, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stephen Michael Kelsey: insider trades and track record | InsiderTell